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Abstract
Scalable expansion of cells for regenerative cell therapy or to produce large quantities for high-throughput screening
remains a challenge for bioprocess engineers. Laboratory scale cell expansion using t-flasks requires frequent passaging
that exposes cells to many poorly defined bioprocess forces that can cause damage or alter their phenotype.
Microcarriers offer a potential solution to scalable production, lending themselves to cell culture processes more
akin to fermentation, removing the need for frequent passaging throughout the expansion period. One main problem
with microcarrier expansion, however, is the difficulty in harvesting cells at the end of the process. Therefore, therapies
that rely on cell delivery using biomaterial scaffolds could benefit from a microcarrier expansion system whereby the cells
and microcarriers are transplanted together. In the current study, we used bioactive glass microcarriers doped with 5%
TiO2 that display a controlled rate of degradation and conducted experiments to assess biocompatibility and growth of
primary fibroblast cells as a model for cell therapy products. We found that the microcarriers are highly biocompatible
and facilitate cell growth in a gradual controlled manner. Therefore, even without additional biofunctionalization
methods, Ti-doped bioactive glass microcarriers offer potential as a cell expansion platform.
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Introduction
The emerging ﬁeld of regenerative medicine incorpo-
rates strategies including cell therapy, biomaterial scaf-
folds and small molecules to stimulate regeneration in
the body. In particular, direct cell delivery or tissue
engineering approaches have the aim of restoring func-
tion of injured or diseased body parts by delivery of
cells or engineered tissues to the defect site.1 This pro-
mising strategy depends on the assumption that cells
can be expanded to produce therapeutic quantities
and then be diﬀerentiated into the appropriate cell
type required in the defect site.
Current limitations to cell therapy include expanding
cells to the desired number for clinical use and the fact
that their extended expansion in culture leads to loss of
multipotency and senescence.2 For example, bioprocess
forces experienced during serial passaging of cells
(including centrifugal, hydrodynamic and capillary
ﬂow shear stress) can have poorly deﬁned and,
indeed, undesired eﬀects on the cells. Moreover,
interactions of adhesion molecules with extracellular
matrix (ECM) ligands required to support cell survival
are cyclically interrupted by trypsinization and
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replating during every passage in 2-dimensional (2D)
monolayer expansion.3 Therefore, reliable and eﬃcient
ex vivo cell expansion methods need to be explored as
alternatives to conventional 2D culture systems.
Microcarriers that oﬀer large surface areas for growth
of anchorage-dependent cells have a potential advan-
tage in that they can be used for the expansion of
adherent cells in a 3D bioreactor using processes that
are more akin to fermentation processes than trad-
itional 2D monolayer cell culture. In recent years, sev-
eral methods of expanding adherent cells have been
reported using diﬀerent types of microcarriers as sub-
strates for cell attachment.4,5 Bead size, surface area
and functional ability to promote cell attachment are
all critical factors that can aﬀect cell adhesion and
ultimately their expansion potential.6
Recent advances in the biomaterials ﬁeld have led to
the development of composite materials, biofunctiona-
lized to complement and enhance biological responses
in living tissues without compromising the natural bio-
logical process. These materials include glasses and
glass-ceramics and can be considered as bioactive
materials.7 One of the measures of bioactivity is the
utilization of simulated body ﬂuid (SBF) in which apa-
tite formed on the surface of a material is taken as an
indicator that the material is bioactive.8 Phosphate-
based glasses are particularly attractive as they are
easy to produce, biodegradable and of known biocom-
patibility with multiple cell types.9,10 They can also be
doped with a variety of metal oxides to modify their
physical properties or induce a speciﬁc function such as
antimicrobial capacity.11 However, they have been
shown to not form an apatite layer in vitro,12 and yet
do upregulate genes associated with bone formation in
cell culture.13
The potential of microcarriers made of such mater-
ials for tissue engineering is signiﬁcant because they
present a potential way in which large quantities of
material could be produced in many small individual
cell-microcarrier units that can then be pieced together
after expansion is accomplished.
In the current study, we selected microcarriers made
from a stable bioactive phosphate glass doped with
5 mol% TiO2 to assess the attachment and expansion of
primary ﬁbroblasts as a model system for somatic cells
used in cell therapy and tissue engineering procedures.
Materials and methods
Glass preparation and microsphere formation
Glasses were synthesized from the precursors: sodium
dihydrogen orthophosphate (NaH2PO4), calcium car-
bonate (CaCO3), phosphorous pentoxide (P2O5) and
titanium dioxide (TiO2) as previously described.
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Three diﬀerent compositions, Ti3, Ti5 and Ti7 were
made, according to the TiO2 content used (Table 1).
The precursors were weighed and mixed and then pre-
heated to 700C for 30min to remove CO2 and H2O.
The mixture was then melted at 1300C for 3 h and then
rapidly quenched onto a steel plate. The phosphate
glasses were ball-milled and sieved down to
75–106mm. The glass particles were then passed
through a ﬂame spheroidization device to produce
microspheres as previously described.12 The size distri-
bution of the resulting microspheres was 10–210mm
and a size range of 63–106mm was selected for use in
subsequent experiments.
Characterization of dissolution and ion release
To determine the change in weight with time, 250mg of
microspheres were placed in 25 ml of deionised water at
pH 7. At 0, 1, 3, 7, 14 and 21 days, the solution was
removed and the samples were oven dried and then
reweighed and the weight loss was calculated as a per-
centage of the original weight. A unique set of samples
was prepared for each time point and each time point
was measured in triplicate.
ICS-1000 ion chromatography system (Dionex, UK)
was used to measure Naþ and Ca2þ release. The separ-
ation was performed using methanesulfonic acid
(Fluka, UK) eluent and a 4 250mm Ion Pac
CS12A separator column. Prior to running a sample,
ion chromatograph was calibrated against a four-point
calibration curve using a predeﬁned calibration routine.
The Chromeleon software package was used for data
analysis.
The phosphate anion measurements were carried out
using a Dionex ICS-2500 ion chromatography system.
Polyphosphates were eluted using a 4 250mm Ion
Pac AS16 anion-exchange column packed with
anion exchange resin. A Dionex anion self-regenerating
suppressor (ASRS) was used at 242mA. The Dionex
EC40 eluent generator equipped with a potassium
hydroxide (KOH) cartridge was used in conjunction
with the ASRS. The sample run time was set for
20min where the gradient program started from
30 mM KOH for 10min, then increased from 30 to
60 mM KOH over 5min, followed by remaining at
Table 1. Glass structural composition.
Glass compositions (mol%)
Glass codes P2O5 CaO Na2O TiO2
P50C40N7Ti3 (Ti3) 50 40 7 3
P50C40N5Ti5 (Ti5) 50 40 5 5
P50C40N3Ti7 (Ti7) 50 40 3 7
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60mM KOH for 3min and ﬁnally the KOH returned
to 30 mM for 2min.
Average microcarrier diameter measurements
Average microcarrier diameter was determined from
light micrograph images of microcarrier monolayers.
The diameter of 200 microcarriers was measured
using the Image J software. Frequency histograms of
size distribution were created in order to determine the
size range of microcarriers employed.
Isolation and culture of primary fibroblasts
Primary ﬁbroblasts were derived from E12.5-13.5 CD-1
mouse embryos in accordance with local animal welfare
guidelines and regulations. Fibroblasts were liberated
from embryonic tissue using the collagenase digestion
methoddescribedpreviously.15Cultureswere established
by plating digested tissue in T-25 ﬂasks and culturedwith
Dulbecco’s Modiﬁed Eagle Medium (DMEM) (4.5 g/L
glucose) supplemented with FBS (10%) and non-essen-
tial amino acids (1%) (all from Invitrogen, Paisley, UK).
Cell cultures were maintained at 37C/5%CO2 and pas-
saged when 80-90% conﬂuent using trypsin-EDTA solu-
tion for 3minat 37C.Cell numberwasquantiﬁedusing a
Neubauer haemocytometer and viability was determined
using the Trypan blue dye exclusion method.
Relative attachment of primary fibroblasts to microcarriers
versus cell culture-grade plastic. Bioactive glass microcar-
riers (15mg/well) were placed into wells of a 96-well
microwell plate (Greiner Bio-One, Stonehouse, UK)
in a monolayer and UV sterilized for 1 h and 40min.
Microcarriers were then equilibrated in 50 mL of pre-
warmed medium to ‘wet’ them and avoid putting the
cell suspension directly onto a dry monolayer of micro-
carriers. Fibroblasts were seeded on microcarriers
(1.5 104 cells in 50 mL of medium) and the plates
were then incubated at 37C and 5%CO2 for 24 h.
Observations of cell attachment to microcarriers com-
pared to the surrounding cell culture plastic were made
using light microscopy and subsequently using ﬂuores-
cence microscopy after staining with DAPI.
Primary fibroblast expansion on microcarriers in
low-adhesion microwell plates
Low attachment 96-well plates (Costar) were used for
cell proliferation studies to prevent undesired cell
attachment to the microwell surface. After sterilizing
as above, microcarriers were equilibrated in 50 mL of
pre-warmed medium. Fibroblasts in 50 mL of medium
were then seeded onto microcarriers at a concentration
of 1.5 104 cells/well and the plates were incubated at
37C/5%CO2 for diﬀerent time periods of up to
14 days. Medium was replaced every 48 h.
Cell staining procedures
Live cell staining was performed by incubating a con-
ﬂuent T-25 ﬂask of ﬁbroblasts with staining solution
consisting of 10 mL Vybrant DiO labeling dye
(Invitrogen) in 2mL of normal growth medium at
37C for 20min. Staining medium was removed and
cells washed three times with PBS.
40, 6-diamidino-2-phenylindole (DAPI) staining was
performed after ﬁxing cells with 4% paraformaldehyde
(PFA) for 10min at room temperature (RT) and wash-
ing with PBS. Cultures were stained with DAPI
(working solution 1:1000) for 5 min at 37C and then
rinsed with PBS.
For actin cytoskeleton labeling, cells were ﬁxed with
4% PFA for 10min at RT and then permeabilized with
0.5% Triton X-100 in PBS for 5min at RT. Cultures
were stained with Acti-stainTM 488 phalloidin (1:140
dilution in PBS) (Cytoskeleton, Inc.) for 30min at RT
in the dark. Counter-staining with propidium iodide
(PI) was performed by ﬁxing cells as above, then per-
meabilizing with 0.1% Triton X-100 in PBS for 5min at
RT. Cells were stained with PI (10mg/mL; Sigma) for
5min at RT in the dark.
PI and phalloidin labeling were visualized by con-
focal microsopy using a Radiance 2100 confocal micro-
scope (BioRad, Loughborough, UK).
Cell proliferation assays
Cell proliferation was measured the Cell Counting Kit-
8 (CCK-8; Sigma). Fibroblasts were seeded onto mono-
layers of bioactive glass microcarriers (15mg/well) in
96-well low adhesion microwell plates at a concentra-
tion of 1.5 104 cells/well and incubated at 37C. At
diﬀerent time points up to 14 days, optical density
was measured at 450 nm in a multi-well Saﬁre2 plate
reader (Tecan). Cells cultured in 96-well tissue culture
grade plates were used as a positive control due to their
capacity to enhance cell proliferation. All samples were
assayed in triplicate and for each experiment the
mean standard deviation was calculated.
Scanning electron microscopy
For scanning electron microscopy (SEM), ﬁbroblasts
(3 104 cells/well) were seeded onto bioactive glass
microcarriers (40mg/well) in 24-well plate tissue culture
inserts (Greiner Bio-One, Stonehouse, UK). After cul-
ture for 1, 3 or 7 days, cells on microcarriers were pre-
pared SEM using established protocols.16 Brieﬂy, cells
were ﬁxed (3% glutaraldehyde in 0.1M cacodylate
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buﬀer for 24 h at 4C), dehydrated, critical-point dried
using hexamethyldisilazane, air-dried and then
mounted onto aluminium pin stubs and coated with
gold/palladium. Samples were examined with a JEOL
5410LV SEM (JEOL UK) operating at 10 kV.
Results
Microcarrier dissolution and ion release
Microcarriers doped with three diﬀerent concentrations
of TiO2 were subjected to dissolution studies to deter-
mine their stability. Figure 1(A) shows the weight change
over time for beads containing 3, 5 and 7 mol% TiO2.
As expected, the glass with the lowest TiO2 content
showed the highest degradation rate and is relatively
linear with time. The glasses containing 5 and 7mol%
TiO2 however appeared to be more stable and showed
very similar patterns of degradation behavior, with an
initial drop in weight up to day 3 and overall losing
around 15% of their total weight at 21 days. Ca2þ
release data also conﬁrmed this (Figure 1(B)), with the
lowest TiO2 content glass releasing Ca
2þ at a greater rate
due to rapid degradation. The glasses with 5 and 7mol%
TiO2 showed relatively similar Ca
2þ release proﬁles, with
the glass containing 5mol% TiO2 having a slightly
higher Ca2þ release proﬁle. All three glasses showed rela-
tively linear Ca2þ release with time. The ionic release of
other ionic species is shown in Table 2. The release rates
were calculated from the respective graphs of ion release
with time, whereby a straight line was ﬁtted through the
data, passing through the origin. All the other ions
showed a similar release pattern to the Ca2þ (data not
shown), diﬀering only in the rates at which the ions were
released. The Ti4þ was not measured due to the very low
levels released, making the measurements unreliable.
Due to the relatively similar stability of Ti5 and Ti7,
we used Ti5 microcarriers for subsequent experiments
using ﬁbroblasts. The mean microcarrier diameter of
the Ti5 batch was 84.2þ 19.4mm and approximately
1450microcarriers were required to cover the surface
of one well of a 96-well microplate. Microscopic appear-
ance and size distribution of a sample of 200 microcar-
riers are shown in Figure 1(C) and (D).
Figure 1. (A) Microcarrier degradation and (B) associated Ca2þ release from Ti3, Ti5 and Ti7 microcarriers over time in deionized
water. (C) Light micrograph of microscopic appearance and (D) size distribution histogram of Ti5 microcarriers used in subsequent
experiments. Bar¼ 100 mm.
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Microscopic characterization and fibroblastic cell affinity of
TiO2-doped microcarriers. Examinations of cell attach-
ment to 5 mol% TiO2 glass microcarriers was con-
ducted initially in standard cell culture plates to
determine whether cells can attach to the microcarrier
surface or instead show preference for the highly per-
missive cell culture grade plastic surface. We observed
that even though many ﬁbroblasts were established on
the tissue culture plastic by 24 h, ﬁbroblasts could read-
ily adhere to the microcarrier surfaces where they came
into contact with them (Figure 2(A) and (B)). Having
conﬁrmed that the microcarriers are not inhibitory to
cell growth when placed in competition with tissue cul-
ture plastic, ﬁbroblasts were then seeded onto micro-
carriers in low-adhesion microwell plates and after 72 h
all cells attached to the microcarriers and not the bot-
tom of the microwell (Figure 2(C)–(E)). Morphology
was assessed in greater detail on 5mol% TiO2-doped
microcarriers after 3 days of culture (Figure 3).
Labeling of the actin cytoskeleton (green) revealed
that ﬁbroblasts wrap themselves around the microcar-
rier and prominent focal adhesion sites are evident
(arrows). Cell nuclei staining also revealed cells actively
dividing on the microcarrier surface (arrowheads).
Fibroblast proliferation capacity on microcarrier
surfaces
Proliferation of primary ﬁbroblasts on TiO2-doped
microcarriers in low-adhesion microwell plates was
assayed under static conditions and compared to rou-
tine cell culture-grade microwell plates that provide
optimal substrate properties to enhance cell expansion.
The CCK proliferation assay revealed that a steady,
sustained expansion of the population was achievable
over 14 days of culture for 2 diﬀerent passages of cells
tested, culminating in a 2-fold increase in the popula-
tion size after 14 days (p< 0.01) (Figure 4). However,
proliferation was only 50% of that in routine cell
culture grade microwell plates.
Interconnectivity and network forming capacity of fibroblast-
microcarrier cultures. Fibroblasts are able not only to
adhere to microcarriers but also readily form 3D
networks in static culture as soon as 24 h after
seeding by bridging across to adjacent microcarriers
and to cells located on adjacent microcarriers
Figure 2. (A) Phase-contrast and (B) DAPI staining of fibroblasts seeded onto standard tissue culture plastic dispersed with
microcarriers after 24 h. (C–D) Adhesion of fibroblasts to microcarriers in ultra-low attachment microwell plates 72 h after seeding.
(E) Clear cell adhesion and growth on microcarriers is evident with propidium iodide (PI) staining at high power after 72 h.
Bar¼ 100mm.
Table 2. Release rate of ionic constituents from microcarriers.
Glass code Ti3 Ti5 Ti7
Anion (ppm h1)
PO34 37.921 5.2563 3.6023
P3O
3
9 46.864 13.304 7.4739
P2O
4
7 15.084 3.2237 2.2045
P3O
5
10 18.761 8.1531 5.5788
Cation (ppm h1)
Ca2þ 45.778 15.202 7.462
Naþ 15.571 1.9666 0.772
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Figure 3. Morphology of fibroblasts cultured on 5 mol% TiO2-doped microcarriers. Green¼ phalloidin f-actin; Red¼ propidium
iodide; arrows¼ focal adhesions; arrowhead¼ dividing cell. Bar¼ 100 mm.
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(Figure 5(A) and (B)). SEM reveals this to an even
greater extent over a period of 7 days culture and
the extensive network of cell processes between
microcarriers reveals that a high degree of biocom-
patibility is evident (Figure 5(C)–(K)) and that the
combined ﬁbroblast-microcarrier system was capable
of forming a large interconnected 3D network.
Discussion
The degradation rate of phosphate glasses, and conse-
quently their biocompatibility, is mainly dependent on
the glass composition; therefore, suitable modiﬁcations
to the glass chemistry are required in order to obtain
stable substrates that degrade slowly and exhibit high
biocompatibility. In the current study, microcarriers
were doped with several diﬀerent concentrations of
TiO2 and while 3 mol% microcarriers were found to
degrade too rapidly to be useful for either scalable
cell expansion or clinical delivery, the 5 and 7 mol%
compositions were structurally stable over the time
period examined. There was evidence of more rapid
initial degradation in the 5 and 7mol% glass and this
may be due to the rate at which Naþ is initially
released, which may come out of these glasses more
quickly. However, the rest of the structure is relatively
more stable in solution, hence the reduction in weight
loss. The 5 mol% TiO2-doped microcarriers were used
Figure 5. (A) Phase contrast and (B) fluorescent images of fibroblasts labelled with Vibrant DiO after 24 h. (C–K) Scanning electron
microscopy (SEM) images showing morphology of fibroblasts over time. Bar A, B, E, H, K¼ 100mm; C, D, F, G, I, J¼ 70mm.
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for subsequent cytocompatibility work using primary
ﬁbroblasts and it was found that cell adhesion and pro-
liferation was supported on the microcarriers. This is
attributable to the known biocompatibility of TiO2.
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Furthermore, after a static culture period of 7 days,
cells formed a large amount of bridging between adja-
cent microcarriers. However, for scalable expansion
processes, dynamic bioreactor culture would be
employed to ensure homogeneous dispersion of micro-
carriers and eﬃcient mixing of nutrients. Signiﬁcant cell
bridging between microcarriers after 7 days of culture
raises the possibility that they would be suitable for
forming dynamic tissue-engineered structures after an
initial period of dynamic culture.
A dynamic approach to scalable cell expansion
amenable to tissue engineering by producing tissue-
engineered microunits would be highly beneﬁcial for
tissue regeneration purposes. However, our aim in the
current study was to demonstrate the biocompatibility
of TiO2-doped glass microspheres and feasibility of the
surface to serve as a suitable surface for cell adhesion
and growth. While cell growth was not as rapid as on
commercially available tissue culture plastic designed
and optimised to enhance cell growth, surface modiﬁ-
cations to the TiO2-doped microcarriers should over-
come this concern. Cell culture grade plastic is surface-
modiﬁed to enhance cell growth and subsequent
improvements to the microcarriers such as biofunctio-
nalization of the surface may be a suitable strategy to
enhance cell growth. Biofunctionalization methods,
such as surface coating with ECM molecules or short
peptides that can mimic extracellular or growth factor
motifs,18 have been successful for polymer-based scaf-
folds of low intrinsic biocompatibility.
Traditional tissue engineering strategies employ a
‘‘top-down’’ approach, in which cells are seeded on
a biodegradable scaﬀold. Using this approach, the
cells are expected to populate the scaﬀold and create
the appropriate ECM and microarchitecture.
However, it is very diﬃcult to replicate tissue micro-
architecture using a top-down approach even in spite
of the wealth of advanced surface biofunctionalization
methods and native decellularized scaﬀolds available.
In a ‘‘bottom-up’’ approach, modular tissue engineer-
ing aims to address the challenge of recreating bio-
mimetic structures by designing structural features
on the micron scale to build modular tissues that
can be used as building blocks to create larger
tissues.19 The use of TiO2-doped microcarriers for
modular tissue engineering is particularly promising
for bone regeneration strategies as titanium is
widely used for orthopaedic and dental procedures,
supporting osteogenesis even when a disease such as
diabetes dampens the intrinsic regeneration
response.20–22
Compared to pre-fabricated bulk scaﬀolds, micro-
carriers oﬀer a range of unique features: (a) expansion
capacity that can be scaled according to the individual
patient requirements such as size of defect; (b) the pos-
sibility of easy and quick injection without larger sur-
gical procedures23; (c) enhanced versatility in ﬁtting the
unique, site-speciﬁc shape of a defect as compared to
a pre-fabricated bulk scaﬀold and (d) homogeneous
distribution of cells throughout an agglomerated
construct of cell-loaded microcarriers. These features
make microcarriers a promising alternative to bulk
scaﬀolds.
Conclusions
TiO2-doped bioactive glass microcarriers oﬀer great
potential as a scalable expansion tool for the cell ther-
apy industry and may also serve a dual purpose by
doubling as a dynamic method for tissue engineering.
Surface modiﬁcations for further biofunctionalization
could yield microcarriers that are valuable tools for
cell expansion and tissue engineering.
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